|
OMIM |
Link |
Information gain |
01 |
|
dermal ridges-off-the-end
|
[NCBI]
|
0.00240735
|
|
|
ASD1
|
[NCBI]
|
0.00188466
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.00156007
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.0011856
|
|
|
IDDM
|
[NCBI]
|
0.00117818
|
|
|
behcet syndrome
|
[NCBI]
|
0.000746092
|
|
|
SPDA1
|
[NCBI]
|
0.000607811
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.000463249
|
|
|
HLA-A
|
[NCBI]
|
0.000400985
|
|
|
h-y antigen receptor
|
[NCBI]
|
0.000391231
|
|
|
ragweed sensitivity
|
[NCBI]
|
0.000373165
|
|
|
PTPRC
|
[NCBI]
|
0.000370884
|
|
|
mixed lymphocyte culture locus ii
|
[NCBI]
|
0.000268082
|
|
|
C4B
|
[NCBI]
|
0.00022749
|
|
|
CFB
|
[NCBI]
|
0.000187222
|
|
|
hla modifier
|
[NCBI]
|
0.000155619
|
|
|
dermal ridges, nelson syndrome
|
[NCBI]
|
0.000155619
|
|
|
PLT1
|
[NCBI]
|
0.000112153
|
|
|
SCA1
|
[NCBI]
|
0.00010821
|
|
|
MBP
|
[NCBI]
|
0.000104824
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
0.000104434
|
|
|
polycystic kidneys
|
[NCBI]
|
0.000101943
|
|
|
SLC39A7
|
[NCBI]
|
9.92166e-05
|
|
|
mast cell disease
|
[NCBI]
|
9.87009e-05
|
|
|
HYR
|
[NCBI]
|
9.03455e-05
|
|
|
IS
|
[NCBI]
|
9.03455e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
8.5243e-05
|
|
|
autoimmune disease
|
[NCBI]
|
7.7451e-05
|
|
|
JARID1D
|
[NCBI]
|
7.70779e-05
|
|
|
IL2
|
[NCBI]
|
7.0535e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
6.80262e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
6.80262e-05
|
|
|
SCCMS
|
[NCBI]
|
6.80262e-05
|
|
|
neural tube defects
|
[NCBI]
|
6.67841e-05
|
|
|
CF
|
[NCBI]
|
6.33359e-05
|
|
|
HSD17B8
|
[NCBI]
|
6.32836e-05
|
|
|
RCC1
|
[NCBI]
|
5.56832e-05
|
|
|
IGER
|
[NCBI]
|
5.49725e-05
|
|
|
MUC1
|
[NCBI]
|
5.37183e-05
|
|
|
CD74
|
[NCBI]
|
5.26198e-05
|
|
|
B2M
|
[NCBI]
|
4.89991e-05
|
|
|
LAD
|
[NCBI]
|
4.74172e-05
|
|
|
MG
|
[NCBI]
|
4.32368e-05
|
|
|
PSORS1
|
[NCBI]
|
4.15268e-05
|
|
|
TRIM39
|
[NCBI]
|
3.90471e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
3.53156e-05
|
|
|
TCRA
|
[NCBI]
|
3.4708e-05
|
|
|
HLA-DRA
|
[NCBI]
|
3.44654e-05
|
|
|
C4A
|
[NCBI]
|
3.33306e-05
|
|
|
MS
|
[NCBI]
|
3.23682e-05
|
|
|
TRIM10
|
[NCBI]
|
3.16272e-05
|
|
|
S5
|
[NCBI]
|
3.16272e-05
|
|
|
RNF14
|
[NCBI]
|
3.16272e-05
|
|
|
C3
|
[NCBI]
|
3.12011e-05
|
|
|
fabry disease
|
[NCBI]
|
2.98251e-05
|
|
|
DTL
|
[NCBI]
|
2.88289e-05
|
|
|
SPAG4
|
[NCBI]
|
2.70129e-05
|
|
|
MRPL13
|
[NCBI]
|
2.70129e-05
|
|
|
B4GALNT2
|
[NCBI]
|
2.56635e-05
|
|
|
EGF
|
[NCBI]
|
2.54811e-05
|
|
|
PKD1
|
[NCBI]
|
2.47044e-05
|
|
|
ART1
|
[NCBI]
|
2.45889e-05
|
|
|
EPS15
|
[NCBI]
|
2.45889e-05
|
|
|
PTPRA
|
[NCBI]
|
2.45889e-05
|
|
|
GNLY
|
[NCBI]
|
2.36959e-05
|
|
|
HPA-2
|
[NCBI]
|
2.36959e-05
|
|
|
DBY
|
[NCBI]
|
2.36959e-05
|
|
|
CD
|
[NCBI]
|
2.3252e-05
|
|
|
tl antigen
|
[NCBI]
|
2.29319e-05
|
|
|
ODF1
|
[NCBI]
|
2.29319e-05
|
|
|
LAG5
|
[NCBI]
|
2.22644e-05
|
|
|
TXK
|
[NCBI]
|
2.22644e-05
|
|
|
CD9
|
[NCBI]
|
2.22644e-05
|
|
|
EMT
|
[NCBI]
|
2.16718e-05
|
|
|
SRA2
|
[NCBI]
|
2.16718e-05
|
|
|
AL-A1
|
[NCBI]
|
2.06552e-05
|
|
|
CD247
|
[NCBI]
|
2.06552e-05
|
|
|
GFI1
|
[NCBI]
|
2.02121e-05
|
|
|
IRF5
|
[NCBI]
|
2.02121e-05
|
|
|
CCL3
|
[NCBI]
|
1.98034e-05
|
|
|
PTPN6
|
[NCBI]
|
1.98034e-05
|
|
|
PGM3
|
[NCBI]
|
1.78555e-05
|
|
|
PTPN22
|
[NCBI]
|
1.78555e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
1.71e-05
|
|
|
CRYAA
|
[NCBI]
|
1.68707e-05
|
|
|
MODY
|
[NCBI]
|
1.64165e-05
|
|
|
GLO1
|
[NCBI]
|
1.62382e-05
|
|
|
PTPN1
|
[NCBI]
|
1.60434e-05
|
|
|
CD4
|
[NCBI]
|
1.58558e-05
|
|
|
AT
|
[NCBI]
|
1.55846e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
1.54998e-05
|
|
|
HLA-B
|
[NCBI]
|
1.50083e-05
|
|
|
PRPH2
|
[NCBI]
|
1.4705e-05
|
|
|
PI
|
[NCBI]
|
1.4274e-05
|
|
|
VEGF
|
[NCBI]
|
1.427e-05
|
|
|
IL2RA
|
[NCBI]
|
1.29757e-05
|
|
|
ITGB2
|
[NCBI]
|
1.23849e-05
|
|
|
JAK3
|
[NCBI]
|
1.10159e-05
|
|
|
HBD
|
[NCBI]
|
1.10159e-05
|
|
|
PRL
|
[NCBI]
|
1.06071e-05
|
|
|
TNF
|
[NCBI]
|
9.99367e-06
|
|
|
GPT
|
[NCBI]
|
9.94969e-06
|
|
|
SRC
|
[NCBI]
|
9.03389e-06
|
|
|
HDAC1
|
[NCBI]
|
8.72156e-06
|
|
|
VIM
|
[NCBI]
|
8.38903e-06
|
|
|
RNASE2
|
[NCBI]
|
7.9686e-06
|
|
|
PG
|
[NCBI]
|
7.82507e-06
|
|
|
INSR
|
[NCBI]
|
7.7899e-06
|
|
|
KITLG
|
[NCBI]
|
6.57688e-06
|
|
|
HFE
|
[NCBI]
|
6.29671e-06
|
|
|
ACHE
|
[NCBI]
|
5.0161e-06
|
|
|
SLE
|
[NCBI]
|
4.53963e-06
|
|
|
NGFB
|
[NCBI]
|
4.2672e-06
|
|
|
KLK3
|
[NCBI]
|
4.25474e-06
|
|
|
EPO
|
[NCBI]
|
2.90839e-06
|
|
|
GFAP
|
[NCBI]
|
2.89534e-06
|
|
|
TG
|
[NCBI]
|
2.33609e-06
|
|
|
TNFSF6
|
[NCBI]
|
2.19093e-06
|
|
|
MPO
|
[NCBI]
|
1.80988e-06
|
|
|
ACP5
|
[NCBI]
|
1.47132e-06
|
|
|
AFP
|
[NCBI]
|
1.40381e-06
|
|
|
RA
|
[NCBI]
|
6.28155e-07
|
|
|
CFTR
|
[NCBI]
|
2.81029e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
3.07867e-08
|
|
|
CEACAM5
|
[NCBI]
|
3.48354e-10
|
|